Table 2.
Nutrient | Lot Number 1 | |
---|---|---|
1 | 2 | |
Fat (acid hydrolysis), % | 99.1 | 99.2 |
Fatty acid concentration, g/100 g | ||
Lauric (C12:0) | 37.3 | 36.5 |
Myristic (C14:0) | 9.68 | 10.00 |
Palmitic (C16:0) | 14.8 | 14.4 |
Palmitoleic (C16:1) | 1.71 | 2.03 |
Stearic (C18:0) | 2.07 | 2.24 |
Oleic (C18:1) | 12.6 | 13.5 |
Linoleic (C18:2) | 17.4 | 17.1 |
α-Linolenic (C18:3) | 1.52 | 1.46 |
Others 2 | 2.02 | 1.94 |
Saturated fatty acids | 65.1 | 64.3 |
Polyunsaturated fatty acids | 19.0 | 18.6 |
Monounsaturated fatty acids | 14.6 | 15.8 |
Trans fatty acids | 0.40 | 0.47 |
Omega 3 fatty acids | 1.52 | 1.46 |
Omega 6 fatty acids | 17.4 | 17.1 |
Omega 9 fatty acids | 12.6 | 13.5 |
1 Lot number 1 was used for phase 1 and 2 diets and lot number 2 was used for phase 3 diets. 2 Other fatty acids analyzed were present at concentrations of less than 0.75% and consisted of: butyric (C4:0), caproic (C6:0), caprylic (C8:0), capric (C10:0), tridecanoic (C13:0), myristoledic (C14:1 trans), myristoleic (C14:1 cis), pentadecanoic (C15:0), almitelaidic (C16:1 trans), heptadecanoic (C17:0), 10-heptadecanoic (C17:1), eliadic (C18:1 trans), linolelaidic (C18:2 trans), γ-linolenic (C18:3 γ), nonadecanoic (C19:0), arachidic (C20:0), 11-eicosenoic (C20:1), 11-14 eicosadienoic (C20:2), homo- γ linolenic (C20:3), 11-14-17 eicosatrienoic (C20:3), arachidonic (C20:4), eicosapentaenoic (C20:5), heneicosanoic (C21:0), behenic (C22:0), erucic (C22:1), docosadienoic (C22:2), docosapentaenoic (C22:5), docosahexaenoic (C22:6), tricosanoic (C23:0), lignoceric (C24:0), and nervonic (C24:1) acid.